Johnson & Johnson plans on paying out $1 billion to settle almost all patient lawsuits involving its all-metal hip implants, although the health care giant still faces other lawsuits related to its other hip implants, Bloomberg reports.
Health care settlements
Justice Department collects more pharma copay settlements
Astellas Pharma is paying $100 million and Amgen is paying almost $25 million to the Department of Justice to settle allegations that they funneled donations to charities, which in return covered patients' copays for those companies' drugs.
The bottom line: The settlements are small potatoes for both drugmakers.